Free CME from PeerView


Pulmonary/Respiratory Medicine CME

PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 24, 2022
PVI, PeerView Institute for Medical Education
Selecting Targeted Treatment for Pediatric and Adult Patients With Uncontrolled, Moderate to Severe Asthma
Leonard B. Bacharier, MD / Monica Kraft, MD
October 17, 2022
PVI, PeerView Institute for Medical Education
Toward a Goal of Breathing Easy: Identifying Which of Your Patients With Chronic Rhinosinusitis With Nasal Polyps Can Benefit From Targeted Biologic Therapy
Anju T. Peters, MD, MS
October 07, 2022
PVI, PeerView Institute for Medical Education
Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right
Nasser Altorki, MD
September 30, 2022
PVI, PeerView Institute for Medical Education
Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings
Brendon M. Stiles, MD
September 30, 2022
PVI, PeerView Institute for Medical Education
Room to Breathe: Leveraging Biologic Agents and Multidisciplinary Care to Optimize Management in Chronic Rhinosinusitis With Nasal Polyps
Jivianne T. Lee, MD, FACS
September 28, 2022
PVI, PeerView Institute for Medical Education
Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and Practical Considerations in Targeting HER2, HER3, TROP2, and Other Alterations in Advanced Lung Cancer
Marina Chiara Garassino, MD
September 25, 2022
PVI, PeerView Institute for Medical Education
Refining Biomarker Testing and Targeted Treatment of NSCLC With Common and Uncommon EGFR Mutations
Natasha B. Leighl, MD, MMSc, FRCPC, FASCO
September 25, 2022
PVI, PeerView Institute for Medical Education
Improving Outcomes in SCLC Through Optimal Integration of the Latest Therapies: Expert Perspectives on the State of the Science, Best Practices, Multidisciplinary Care, and Future Directions
Taofeek K. Owonikoko, MD, PhD
September 24, 2022
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
Alexander Drilon, MD
September 02, 2022
PVI, PeerView Institute for Medical Education
Controlling Moderate to Severe Asthma Across the Lifespan in an Ever-Evolving Treatment Landscape: How Much Do You Know?
Wanda Phipatanakul, MD, MS
August 25, 2022
PVI, PeerView Institute for Medical Education
Addressing the Underlying Inflammation of Non–Cystic Fibrosis Bronchiectasis: Exploring Novel Treatments to Change Disease Course for Patients and Improve Quality of Life
Cedric "Jamie" Rutland, MD
August 23, 2022
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
PVI, PeerView Institute for Medical Education
Confronting the Challenges of Nontuberculous Mycobacterial Lung Disease: Expert Strategies for Reducing Diagnostic Delays and Improving Adherence to Guideline-Based Treatment
Julie V. Philley, MD / Kevin Winthrop, MD, MPH
August 09, 2022
Johns Hopkins University School of Medicine
Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Shmuel Shoham, MD
July 08, 2022
PVI, PeerView Institute for Medical Education
Assessing the Impact of Therapeutic Advances in SCLC: Instilling New Hope and Moving in Leaps and Bounds Toward Better Outcomes
Jacob Sands, MD
July 04, 2022
PVI, PeerView Institute for Medical Education
Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy From Advanced to Early Disease
David P. Carbone, MD, PhD
June 28, 2022
PVI, PeerView Institute for Medical Education
The Power of Interprofessional Teams in SSc-ILD: From Diagnosis Through Management
Lisa H. Lancaster, MD
June 21, 2022
PVI, PeerView Institute for Medical Education
Find the Targets, Treat With Precision: Modern Principles and New Advances in Biomarker-Driven Lung Cancer Care
Stephen V. Liu, MD
June 05, 2022
PVI, PeerView Institute for Medical Education
Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients: A Strategy to Amplify Immune Response and Enhance or Restore Antitumor Activity
Zev A. Wainberg, MD
May 31, 2022
PVI, PeerView Institute for Medical Education
Airway Inflammation Isn’t the Only Problem: Shining a Light on the Role of Airway Hyper-Responsiveness in Severe Asthma
Jonathan Corren, MD
May 26, 2022
Medical Learning Institute, Inc.
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans to Improve Outcomes in Resectable NSCLC
Nasser Altorki, MD
May 15, 2022
PVI, PeerView Institute for Medical Education
Tackling the Challenge of Treating Severe Asthma: Taking Aim at the Airway Epithelium
Professor Andrew Menzies-Gow
May 04, 2022
PVI, PeerView Institute for Medical Education
Tackling the Practicalities of Antibody–Drug Conjugate Therapy for Solid Tumors: Improving Clinical Care With HER2-, HER3-, and TROP2-Targeted Therapies
Linda Ahn, MSN, ANP-BC, AOCNP
April 28, 2022
PVI, PeerView Institute for Medical Education
Weighing the Evidence, Parsing the Practicalities: Integrating New Treatment Options Into the SCLC Treatment Arsenal to Improve Patient Outcomes in Oncology Practice
Jacob Sands, MD
April 27, 2022
PVI, PeerView Institute for Medical Education
Expanding Options, Lingering Questions: How to Select the Right Immunotherapy for First-Line Treatment of Advanced NSCLC
Mark A. Socinski, MD
April 20, 2022
Medical Learning Institute, Inc.
How I Think, How I Treat—Assessing, Managing, and Engaging Patients With Uncontrolled, Moderate to Severe Asthma: Comparing Approaches With Experts Around the World
Michael E. Wechsler, MD
April 12, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Medical Learning Institute, Inc.
Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD
March 23, 2022

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView